Alnylam Pharmaceuticals Price Target Raised to $295.00/Share From $215.00 by Stifel
Alnylam Pharmaceuticals Price Target Raised to $295.00/Share From $215.00 by Stifel
阿里拉姆制药目标股价由Stifel从215美元/股上调至295美元/股。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册